Leigh Day, a UK law firm, is investigating a potential legal claim against AGC Chemicals Europe on behalf of residents in Thornton-Cleveleys, Lancashire, who believe elevated kidney cancer rates in their area stem from PFOA contamination originating from the company's nearby plant. This marks the first formal legal step in a dispute that has been building for years.

PFOA (perfluorooctanoic acid) belongs to a group of synthetic chemicals called PFAS — per- and polyfluoroalkyl substances. These chemicals are used widely in industry and consumer products because they resist heat and staining. In 2023, the World Health Organization classified PFOA as a Group 1 carcinogen, meaning it is known to cause cancer in humans. That classification has significant consequences: it strengthens the legal and regulatory case against any company found to have released it into the environment. Leigh Day confirms its investigation into alleged contamination of allotment plots near the AGC facility is ongoing. Testing has detected PFOA at some residential properties in the town, according to the BBC.

What's in the Ground and Water

AGC Chemicals Europe says it has stopped using PFOA, but stopping production does not erase what has already seeped into soil and water. Since June 2025, residents have been told not to eat locally grown produce because of contamination concerns, the BBC reported. Soil contamination from PFOA near the plant has been independently confirmed. PFAS chemicals don't break down under normal conditions — they persist indefinitely, which is why they're nicknamed "forever chemicals."

The contamination isn't confined to gardens. The Guardian reported in February 2023 that toxic substances from the AGC site had been found in a protected river. By October 2025, The Guardian reported that the Environment Agency had overlooked PFAS contamination in the Lancashire area — a finding that raises questions about whether regulators adequately monitored what appears to have been a long-term, ongoing release.

In March 2026, the Health and Safety Executive began consulting on whether a type of PFAS emitted from the Lancashire facility should be classified as a possible carcinogen, per ENDS Report. This reflects a step-by-step tightening of how the UK classifies chemicals as hazardous — though formal reclassification will follow from the WHO's 2023 determination rather than lead it.

The Health Question: Where Evidence and Dispute Collide

Public health authorities have not confirmed that PFOA caused the kidney cancers residents are concerned about. A review by public health bodies found no unusual increase in kidney cancer cases in the area and found no link between kidney cancer and environmental contamination or proximity to the industrial zone, according to Wyre Council. Leigh Day's investigation, however, proceeds on the assumption that the connection deserves full legal examination.

The broader context here: UK public health authorities have published a scoping review of airborne PFOA and other PFAS that cites epidemiological studies showing associations between PFAS exposure and cancers, hormone disruption, and weakened immune systems. But an association at the population level — where researchers track patterns across thousands of people — is different from proving that a specific person's cancer was caused by PFAS exposure. That distinction will be central to any legal case. Proving that someone's individual kidney tumor came from the AGC facility, and not from some other cause, is precisely the kind of complex, multi-decade exposure question that environmental lawsuits turn on — and where plaintiffs often struggle to meet the burden of proof.

The picture is genuinely contested. The question legal discovery will test is whether Leigh Day can build an evidentiary case strong enough to proceed.

What Happens Next

The convergence of several developments — a WHO Group 1 carcinogen classification, confirmed residential soil contamination, an HSE consultation on carcinogen reclassification, and now a law firm investigation — creates a different landscape than existed two years ago. Each alone might not be enough to compel action. Together, they narrow the room for maneuver available to the company and regulators alike.

For Leigh Day, the investigative phase focuses on answering three questions: Did residents have exposure to PFOA? Did they suffer harm (the kidney cancers)? Can exposure be linked to harm? Each is a factual burden the firm must establish. The firm has handled analogous environmental contamination cases before, mainly involving overseas mining operations, but environmental PFAS litigation of this domestic scale remains relatively novel in English courts.

The Environment Agency's role matters. If the October 2025 reporting by The Guardian accurately characterizes regulatory gaps, that could influence both how regulators enforce the law going forward and whether residents' lawyers can argue that public oversight failures contributed to the problem — an additional legal angle, though a difficult one to prosecute.

For residents on the ground, the situation is simpler and more immediate. They cannot eat from their own gardens, a restriction that has now stretched into at least its second year. That is the lived reality beneath the legal and scientific debate.